Measurable residual disease testing in acute myeloid leukaemia - Hourigan, C S; Gale, R P; Gormley, N J; Ossenkoppele, G J; Walter, R B (Leukemia, 2017)
Keywords: 692/308/2779/109; 692/699/1541/1990/283/1897; Abnormalities; Acute myelocytic leukemia; Acute myeloid leukemia; Assaying; Cancer Research; Care and treatment; Clinical trials; Critical Care Medicine; Cytogenetics; Decision Making; Drug and Narcotic Control; Drug Discovery; Hematology; Humans; Intensive; Internal Medicine; Intervention; Leukemia; Leukemia, Myeloid, Acute - diagnosis; Leukemia, Myeloid, Acute - drug therapy; Medical tests; Medicine; Medicine & Public Health; Minimal residual disease; Neoplasm, Residual - diagnosis; Oncology; Phenotypes; Predictions; Recurrence; Remission; review; Risk; Standardization; Therapy